Abstract
Pseudomonas keratitis is currently treated with antibiotics with a variable success rate. Part of the morbidity caused by pseudomonas is due to the action of lipopolysaccharide (LPS) present on the surface membrane of the bacteria. Specific IgG present in equine anti-LPS hyper-immune plasma has been found to bind to the LPS from a range of Gram-negative bacteria, including pseudomonas, and by activating complement it destroys these bacteria. Anti-LPS plasma was therefore used as a therapeutic agent in experimentally induced pseudomonas keratitis in rabbits. Thirteen out of 15 (86.7%) anti-LPS treated eyes improved, whereas four out of 17 (23.5%) saline treated control eyes improved (chi 2 = 12.76 p less than 0.001) No ill effects were noted when anti-LPS was administered to healthy rabbit or baboon eyes. Anti-LPS thus was protective in pseudomonas keratitis, and clinical trials appear to be warranted.
Full text
PDF




Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Belmont J. B., Ostler H. B., Dawson C. R., Schwab I., Dulay D. Noninfectious ring-shaped keratitis associated with Pseudomonas aeruginosa. Am J Ophthalmol. 1982 Mar;93(3):338–341. doi: 10.1016/0002-9394(82)90536-0. [DOI] [PubMed] [Google Scholar]
- Bergan T. Pathogenetic factors of Pseudomonas aeruginosa. Scand J Infect Dis Suppl. 1981;29:7–12. [PubMed] [Google Scholar]
- Bohigian G., Okumoto M., Valenton M. Experimental pseudomonas keratitis. Treatment with and evaluation of carbenicillin and gentamicin in combination. Arch Ophthalmol. 1971 Oct;86(4):432–437. doi: 10.1001/archopht.1971.01000010434013. [DOI] [PubMed] [Google Scholar]
- Bohigian G., Valenton M., Okumoto M., Caraway B. L. Collagenase inhibitors in Pseudomonas keratitis. Adjuncts to antibiotic therapy in rabbits. Arch Ophthalmol. 1974 Jan;91(1):52–56. doi: 10.1001/archopht.1974.03900060056014. [DOI] [PubMed] [Google Scholar]
- Burns R. P. Pseudomonas aeruginosa keratitis: mixed infections of the eye. Am J Ophthalmol. 1969 Feb;67(2):257–262. doi: 10.1016/0002-9394(69)93156-0. [DOI] [PubMed] [Google Scholar]
- Fisher M. W. Development of immunotherapy for infections due to Pseudomonas aeruginosa. J Infect Dis. 1974 Nov;130 (Suppl)(0):S149–S151. doi: 10.1093/infdis/130.supplement.s149. [DOI] [PubMed] [Google Scholar]
- Furgiuele F. P. Treatment of pseudomonas infection of the rabbit cornea. Comparative study. Am J Ophthalmol. 1968 Aug;66(2):276–279. doi: 10.1016/0002-9394(68)92074-6. [DOI] [PubMed] [Google Scholar]
- Gaffin S. L., Grinberg Z., Abraham C., Birkhan J., Shechter Y. Protection against hemorrhagic shock in the cat by human plasma containing endotoxin-specific antibodies. J Surg Res. 1981 Jul;31(1):18–21. doi: 10.1016/0022-4804(81)90025-1. [DOI] [PubMed] [Google Scholar]
- HARBIN T. RECURRENCE OF A CORNEAL PSEUDOMONAS INFECTION AFTER TOPICAL STEROID THERAPY: REPORT OF A CASE. Am J Ophthalmol. 1964 Oct;58:670–674. doi: 10.1016/0002-9394(64)91386-8. [DOI] [PubMed] [Google Scholar]
- Hessburg P. C., Truant J. P., Penn W. P. Treatment of Pseudomonas keratitis in rabbits. Am J Ophthalmol. 1966 Jan;61(1):49–54. doi: 10.1016/0002-9394(66)90746-x. [DOI] [PubMed] [Google Scholar]
- Howes E. L., Jr, Aronson S. B., McKay D. G. Ocular vascular permeability. Effect of systemic administration of bacterial endotoxin. Arch Ophthalmol. 1970 Sep;84(3):360–367. doi: 10.1001/archopht.1970.00990040362017. [DOI] [PubMed] [Google Scholar]
- Mondino B. J., Rabin B. S., Kessler E., Gallo J., Brown S. I. Corneal rings with gram-negative bacteria. Arch Ophthalmol. 1977 Dec;95(12):2222–2225. doi: 10.1001/archopht.1977.04450120128019. [DOI] [PubMed] [Google Scholar]
- Smith C. R., Lipsky J. J., Laskin O. L., Hellmann D. B., Mellits E. D., Longstreth J., Lietman P. S. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med. 1980 May 15;302(20):1106–1109. doi: 10.1056/NEJM198005153022002. [DOI] [PubMed] [Google Scholar]
- WIGGINS R. L. Experimental studies on the eye with polymyxin B. Am J Ophthalmol. 1952 May;35(5 2):83–100. doi: 10.1016/0002-9394(52)90261-4. [DOI] [PubMed] [Google Scholar]